HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
about
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsMHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsMUTYH the base excision repair gene family member associated with colorectal cancer polyposisCarcinogenesis and microsatellite instability: the interrelationship between genetics and epigeneticsPrognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study.Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patientsAnticipation in lynch syndrome: where we are where we goReprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutationLow density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer.Mutanome and expression of immune response genes in microsatellite stable colon cancerNuclear localization of CXCR4 determines prognosis for colorectal cancer patientsCombined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells.Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patientsImmune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.Towards a vaccine to prevent cancer in Lynch syndrome patients.Microsatellite instability: an update.The PD-1 expressing immune phenotype of T cell exhaustion is prominent in the 'immunoreactive' microenvironment of colorectal carcinoma.Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.Clinical impact of HLA class I expression in rectal cancer.Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer.High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.
P2860
Q21328691-CBFEAD9A-331F-490D-A9FB-EEC9D23777B1Q26866479-F3AE5BCB-6F97-4368-9DC1-47A090E389FAQ26998490-E6116A2E-F19E-4CDF-A30E-89BF884BBFD8Q28253670-596F0FFB-03D5-44A7-BE70-E0FBB98394A7Q33890118-E3A54EB6-CD0B-41D2-A2E2-CE6FA0B0FC0BQ34252077-75B052D3-AD3D-4FEE-86BF-DC7B13F3FB83Q34264310-628865BB-9D43-41A0-A5B7-196CF35EADA2Q34315826-33A15E90-D089-4C0E-A7EC-B9CB4B7BCB70Q35560811-FED5D626-C588-434A-98FB-1DC5E0886E73Q35799094-41181EDB-890C-418B-96EF-2E9BBB8FF735Q36287080-64C42F1E-875A-40AD-BFE9-366101986A9CQ36711013-601C6D5C-CBD0-421D-AEB4-01F78A8EFF11Q37109573-EAAB2FF1-CF65-4259-A8C9-CD6AAAE54090Q37456485-2AC05DE7-B91A-4E2F-8B9D-23542693288FQ37507346-D3430571-238D-4D46-B0DF-0FAFF7BFD8C6Q37575208-D317B5BB-8BBE-4598-960B-4B19FCED3A54Q37605030-BD743F1B-44C6-4BB5-BAEA-7107E6D21360Q37699262-3D8E3CD7-9444-4684-B8FB-FF13566B4ED5Q37880662-3B806711-FFE0-4203-8FA5-9A34385D3304Q38113960-82D29FC9-7C5C-437A-88B8-75E0648EF19DQ38363519-AFD4C9A2-9D9B-41CF-82CA-F24132496670Q38850314-7417318B-2C4B-4E4D-985F-4CED87C3AE75Q38868401-10D76F24-3380-4759-99BF-ABDAC1AC0416Q39833507-9B5DA2C0-097C-4CA2-82A5-3131AF54A505Q40173498-AB0F0AD2-0DBD-4D59-AB70-C84993E1709BQ43694707-3B7626B2-8401-4B47-9C7F-3A58B5893CB9Q52737068-28B589A8-04B9-4E0D-9DFC-175140D29FDDQ53081522-91D55DC0-B4AB-44BA-9AEE-44B2C2C45AAE
P2860
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
HNPCC versus sporadic microsat ...... oss of HLA class I expression.
@ast
HNPCC versus sporadic microsat ...... oss of HLA class I expression.
@en
type
label
HNPCC versus sporadic microsat ...... oss of HLA class I expression.
@ast
HNPCC versus sporadic microsat ...... oss of HLA class I expression.
@en
prefLabel
HNPCC versus sporadic microsat ...... oss of HLA class I expression.
@ast
HNPCC versus sporadic microsat ...... oss of HLA class I expression.
@en
P2093
P2860
P356
P1433
P1476
HNPCC versus sporadic microsat ...... loss of HLA class I expression
@en
P2093
Cees J Cornelisse
Gert Jan Fleuren
Hans Morreau
Jan Willem F Dierssen
Marjo van Puijenbroek
Soldano Ferrone
P2860
P2888
P356
10.1186/1471-2407-7-33
P407
P577
2007-02-22T00:00:00Z
P5875
P6179
1023603426